Understanding how obesity affects immune function could reshape personalized medicine approaches, particularly as emerging evidence reveals that men and women experience fundamentally different immune consequences from excess weight. This insight challenges the one-size-fits-all approach to obesity treatment and suggests targeted interventions may yield superior outcomes.
The comprehensive analysis demonstrates that biological sex creates distinct patterns of fat distribution and inflammatory responses during obesity. Males and females show markedly different adipose tissue inflammation profiles and adipocytokine production, leading to sex-specific metabolic consequences. These differences extend beyond fat storage to encompass how obesity disrupts both innate and adaptive immune responses, affecting susceptibility to infections, vaccine effectiveness, autoimmune conditions, cancer risk, and cardiovascular disease.
The mechanistic drivers include sex steroids and chromosome complements that influence where fat accumulates, how adipose tissue becomes inflamed, gut microbiota composition, and systemic inflammatory cascades. These biological factors create measurably different immune dysfunction patterns between sexes, yet remain largely overlooked in current obesity research protocols.
This represents a significant gap in translational medicine. Most preclinical and clinical obesity studies fail to adequately analyze sex-based differences, potentially missing crucial therapeutic targets. The review's synthesis of animal model data and human studies provides compelling evidence that sex-stratified research could unlock more effective obesity interventions. For health-conscious adults, this suggests that future obesity treatments, metabolic health strategies, and even preventive care recommendations may need gender-specific calibration to maximize effectiveness and minimize disease risk.